期刊文献+

2016—2018年某三甲医院碳青霉烯类非敏感铜绿假单胞菌的临床分布及耐药性变迁 被引量:4

Clinical distribution and drug resistance tendency of carbapenem-non-susceptible of Pseudomonas aeruginosa in a tertiary hospital from 2016 to 2018
下载PDF
导出
摘要 目的 了解内蒙古鄂尔多斯市某三甲医院铜绿假单胞菌(Pseudomonas aeruginosa, PA)临床分离株的分布,碳青霉烯类非敏感铜绿假单胞菌(carbapenem-non-susceptible of Pseudomonas aeruginosa, CnSPA)流行情况,及PA耐药性的变迁,为抗菌药物合理应用提供依据。方法 收集2016—2018年临床科室培养标本中分离CnSPA的标本信息及其药敏数据,分析CnSPA的标本、科室来源,以及与患者年龄、性别间的关系,并计算CnSPA/PA的构成比。结果 3年间共分离PA 179株,分离株数呈逐年递增趋势;PA菌株主要分离自痰(73.2%),其次为尿(6.7%)和创面分泌物(6.7%)。共分离CnSPA 73株,分离株数呈逐年递增趋势;CnSPA菌株主要分离自痰(86.3%),创面分泌物(6.8%)。CnSPA最常见于外科(占32.9%),而CnSPA/PA的构成比ICU居于首位(87.5%)。CnSPA多分离于61~70岁年龄段人群,以男性为主。PA菌株中CnSPA构成比呈逐年升高的趋势,亚胺培南和美罗培南耐药率也呈逐年升高趋势。其他常用抗菌药物均有耐药率下降趋势,其中阿米卡星和哌拉西林/他唑巴坦耐药率最低。结论 该院CnSPA分离率较高,主要分离自痰标本、外科、老年男性患者,ICU的CnSPA/PA的构成比居于首位,应针对不同科室及人群加强医院感染防控措施,强化碳青霉烯类药物临床合理使用,预防和控制CnSPA的产生和传播。 Objective To understand the distribution of clinical isolates of Pseudomonas aeruginosa(PA), drug resistance and prevalence of carbapenem-non-susceptible PA(CnSPA) in a tertiary first-class hospital in Ordos Inner Mongolia, and the change of drug resistance of PA, so as to provide evidence for rational use of antimicrobial agents.Methods Specimen information and antimicrobial susceptibility data of CnSPA isolated from cultured specimens of clinical departments from 2016 to 2018 were collected, sources of specimens and department of CnSPA, relationship between CnSPA and age as well as sex of patients were analyzed, and isolation rates of CnSPA/PA were calculated.Results A total of 179 PA strains were isolated in the past three years, and the number of isolated PA increased year by year. Strains were mainly isolated from sputum(73.2%), followed by urine(6.7%) and wound secretion(6.7%). A total of 73 CnSPA strains were isolated in the past three years, the number of isolated CnSPA increased year by year.Strains were mainly isolated from sputum(86.3%), followed by wound secretion(6.8%). CnSPA was most common in the department of surgery(32.9%), while CnSPA/PA was the highest in ICU(87.5%). CnSPA was mostly isolated from 61~70-year-old people and mainly male. Among PA strains, the percentage of CnSPA showed an increasing trend year by year, as well as the resistance rate of Imipenem and Meropenem. The resistance rates of other antibiotics showed an reducing trend year by year, among which amikacin and piperacillin-tazobactam had the lowest resistance rates.Conclusion The isolation rate of CnSPA in this hospital was high, strains were mainly from sputum, the department of surgery and old men. CnSPA/PA was the highest in ICU. Prevention and control measures of hospital infections should be strengthened according to departments and populations, and management of clinical use of carbapenem antimicrobial agents should be strengthened to prevent and control the occurrence and prevalence of CnSPA.
作者 彭召红 张娜 张洪涛 李晓华 曹青凤 Peng Zhao-hong;Zhang Na;Zhang Hong-tao;Li Xiao-hua;Cao Qing-feng(Department of Laboratory Medicine in Kangbashi,Ordos Central Hospital,Ordos 017010)
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2022年第6期596-601,共6页 Chinese Journal of Antibiotics
基金 鄂尔多斯市中心医院自主科研项目(No.EY2019014)。
关键词 铜绿假单胞菌 非敏感碳青霉烯类 临床分布 耐药性 Pseudomonas aeruginosa Carbapenem-non-susceptible Clinical distribution Drug resistance
  • 相关文献

参考文献7

二级参考文献60

  • 1胡必杰,魏丽,张秀珍,唐英春,倪语星,黎毅敏,郭纪全,胡云建,张扣兴,杨莉.医院获得性肺炎发病时间对病原构成影响的回顾性队列研究[J].中华结核和呼吸杂志,2005,28(2):112-116. 被引量:48
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:788
  • 3Gaynes R,Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli[J].{H}Clinical Infectious Diseases,2005.848-854.
  • 4Neuhauser MM,Weinstein RA,Rydman R. Antibiotic resistance among gram-negative bacilli in US intensive care units:implications for fluoroquinolone use[J].{H}JAMA:the Journal of the American Medical Association,2003.885-888.
  • 5Fujitani S,Sun HY,Yu VL. Pneumonia due to Pseudomonas aeruginosa:part Ⅰ:epidemiology,clinical diagnosis,and source[J].{H}CHEST,2011.909-919.
  • 6Fine MJ,Smith MA,Carson CA. Prognosis and outcomes of patients with community-acquired pneumonia.A meta-analysis[J].{H}JAMA:the Journal of the American Medical Association,1996.134-141.
  • 7Parameswaran GI,Sethi S. Pseudomonas infection in chronic obstructive pulmonary disease[J].Future Microbiol,2012.1129-1132.
  • 8Robert A,Bonomo RA,Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa[J].{H}Clinical Infectious Diseases,2006,(Suppl 2):S49-S56.
  • 9Woodhead M,Blasi F,Ewig S. Guidelines for the management of adult lower respiratory tract infections--full version[J].{H}Clinical Microbiology and Infection,2011,(Suppl 6):El-59.
  • 10Murphy TF,Brauer AL,Eschberger K. Pseudomonas aeruginosa in chronic obstructive pulmonary disease[J].{H}American Journal of Respiratory and Critical Care Medicine,2008.853-860.

共引文献1195

同被引文献53

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部